nancy lynn snyderman MD insider trades

Open-market stock purchases and sales by nancy lynn snyderman MD, Director at Alkermes plc., from SEC Form 4 filings since Sep 14, 2016.

Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +4%.

Recent trades

DateStockTradeValue
Aug 3, 2026ALKS Alkermes plc.Sold$2.2M
Aug 3, 2026ALKS Alkermes plc.Bought (not open market)—
Aug 3, 2026ALKS Alkermes plc.Bought (not open market)—
May 21, 2026ALKS Alkermes plc.Sold (not open market)$54.5K
May 21, 2026ALKS Alkermes plc.Bought (not open market)—
May 20, 2026ALKS Alkermes plc.Bought (not open market)—
May 20, 2026ALKS Alkermes plc.Bought (not open market)—

Companies traded

  • ALKS Alkermes plc.: 1 buy, 1 sale, last Aug 3, 2026
  • LYRA Lyra Therapeutics, Inc: 1 buy, last May 14, 2025
  • AXNX Axonics, Inc: 1 buy, last Nov 15, 2024
  • FHLT Future Health ESG Corp: 1 buy, last Oct 24, 2021

Get free alerts when nancy lynn snyderman MD files a new trade →